Increased Left Ventricular Mass and Hypertrophy Are Associated with Increased Risk for Sudden Death
Overview
Authors
Affiliations
Objectives: This study examined the relations of echocardiographically determined left ventricular (LV) mass and hypertrophy to the risk of sudden death.
Background: Echocardiographic LV hypertrophy is associated with increased risk for all-cause mortality and cardiovascular disease morbidity and mortality. However, little is known about the association of echocardiographic LV hypertrophy with sudden death.
Methods: We examined the relations of LV mass and hypertrophy to the incidence of sudden death in 3,661 subjects enrolled in the Framingham Heart Study who were > or =40 years of age. The baseline examination was performed from 1979 to 1983 and LV hypertrophy was defined as LV mass (adjusted for height) > 143 g/m in men and > 102 g/m in women. During up to 14 years of follow-up there were 60 sudden deaths. Cox models examined the relations of LV mass and LV hypertrophy to sudden death risk after adjusting for known risk factors.
Results: The prevalence of LV hypertrophy was 21.5%. The risk factor-adjusted hazard ratio (HR) for sudden death was 1.45 (95% confidence interval [CI] 1.10 to 1.92, p=0.008) for each 50-g/m increment in LV mass. For LV hypertrophy, the risk factor-adjusted HR for sudden death was 2.16 (95% CI 1.22 to 3.81, p=0.008). After excluding the first 4 years of follow-up, both increased LV mass and LV hypertrophy conferred long-term risk of sudden death (HR 1.53, 95% CI 1.01 to 2.28, p=0.047 and HR 3.28, 95% CI 1.58 to 6.83, p=0.002, respectively).
Conclusions: Increased LV mass and hypertrophy are associated with increased risk for sudden death after accounting for known risk factors.
Wang B J Cardiovasc Dev Dis. 2025; 12(2).
PMID: 39997480 PMC: 11856785. DOI: 10.3390/jcdd12020046.
Sex and Gender Differences in Ventricular Arrhythmias.
Warnock R, Modi R, Westerman S US Cardiol. 2024; 17:e12.
PMID: 39559519 PMC: 11571389. DOI: 10.15420/usc.2022.38.
AI-based cluster analysis enables outcomes prediction among patients with increased LVM.
Loutati R, Kolben Y, Luria D, Amir O, Biton Y Front Cardiovasc Med. 2024; 11:1357305.
PMID: 39285853 PMC: 11402694. DOI: 10.3389/fcvm.2024.1357305.
van Driest F, van der Geest R, Omara S, Broersen A, Dijkstra J, Jukema J Eur Heart J Imaging Methods Pract. 2024; 2(3):qyae069.
PMID: 39224625 PMC: 11367951. DOI: 10.1093/ehjimp/qyae069.
Yu Z, Gong H, Kesteven S, Guo Y, Wu J, Li J Nat Cardiovasc Res. 2024; 1(6):577-591.
PMID: 39195867 PMC: 11358016. DOI: 10.1038/s44161-022-00082-0.